Behavioral: Long-term care facilities in the intervention arm will receive education and feedback audit on performance
Phase 2 Phase 3
Intervention Model: Crossover Assignment
Primary Purpose: Prevention
Number of new prescriptions for FDA-Approved osteoporosis medications.
Secondary Outcome Measures: Changes in number of bone mineral density test ordered, change in the number of hip protectors issued, change in the number of prescriptions for calcium and vitamin D, changes in the rate of new osteoporotic fractures.
Child, Adult, Senior
January 24, 2006
October 17, 2007
Duke University Medical Center Durham, North Carolina, United States
† Study has passed its completion date and status has not been verified in more than two years.